Greenwich LifeSciences (GLSI) Stock Price, Quote, News & History

Q: What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Greenwich LifeSciences Inc (GLSI) Stock Price, Quote, News & History

GLSINASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$29.00

3.8115.13%

At close: Feb 6, 4:00 PM EST

$28.09

-0.91-3.14%

After Hours: Feb 6, 7:23 PM EST

Overview

News Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$25.40

Close

$29.00

Volume / Avg.

302.89K / 516.92K

Day Range

$24.76 - $29.00

52 Wk Range

7.78 - 34.10

Market Cap

$375.52M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

24.22%

Days to Cover

3.41

Recent Greenwich Lifesciences Inc News

Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Greenwich LifeSciences Stock Jumps After FDA Update

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares are trading higher after the company announced the Food and Drug Administration approved the use of its first commercially manufactured GP2 lot for the FLAMINGO-01 Phase III clinical trial.

Dylan Berman

Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.59M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

6.58M

Free Cash Flow (TTM)

-8.59M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-2.02M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$396.45M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

159.73

Earnings Yield % (TTM)

-5.80%

Earnings Yield % (FWD)

-4.92%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.16

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$3.81M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$25.40

Close

$29.00

Volume / Avg.

302.89K / 516.92K

Day Range

$24.76 - $29.00

52 Wk Range

7.78 - 34.10

Market Cap

$375.52M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

24.22%

Days to Cover

3.41

About

Sector

Health Care

Industry

Biotechnology

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Greenwich LifeSciences (GLSI) stock?

A

You can purchase shares of Greenwich LifeSciences (NASDAQ:GLSI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Greenwich LifeSciences (GLSI) competitors?

A

Other companies in Greenwich LifeSciences’s space includes: Zura Bio Ltd (NASDAQ:ZURA), Burning Rock Biotech Ltd (NASDAQ:BNR), Immuneering Corp (NASDAQ:IMRX), PepGen Inc (NASDAQ:PEPG) and Armata Pharmaceuticals Inc (AMEX:ARMP).

Q

What is the forecast, or price target, for Greenwich LifeSciences (GLSI) stock?

A

Greenwich LifeSciences has a consensus price target of $50.00.

Q

What is the current price for Greenwich LifeSciences (GLSI)?

A

The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $28.09 last updated February 6, 2026 at 7:23 PM EST.

Q

Does Greenwich LifeSciences (GLSI) pay a dividend?

A

There are no upcoming dividends for Greenwich LifeSciences.

Q

When is Greenwich LifeSciences (NASDAQ:GLSI) reporting earnings?

A

Greenwich LifeSciences does not have any upcoming earnings scheduled.

Q

Is Greenwich LifeSciences (GLSI) going to split?

A

There is no upcoming split for Greenwich LifeSciences.

Q

What sector and industry does Greenwich LifeSciences (GLSI) operate in?

A

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Burning Rock Biotech Ltd

Armata Pharmaceuticals Inc

Bicycle Therapeutics PLC

NASDAQ:BCYC

$5.50

-2.83%

Aldeyra Therapeutics Inc

NASDAQ:ALDX

$5.42

-1.99%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$25.40

Close

$29.00

Volume / Avg.

302.89K / 516.92K

Day Range

$24.76 - $29.00

52 Wk Range

7.78 - 34.10

Market Cap

$375.52M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

24.22%

Days to Cover

3.41

Recent Greenwich Lifesciences Inc News

Sarepta Therapeutics, Lands' End, USA Rare Earth, CoreWeave And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Greenwich LifeSciences Stock Jumps After FDA Update

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares are trading higher after the company announced the Food and Drug Administration approved the use of its first commercially manufactured GP2 lot for the FLAMINGO-01 Phase III clinical trial.

Dylan Berman

Why OceanFirst Financial Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.59M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

6.58M

Free Cash Flow (TTM)

-8.59M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-2.02M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$396.45M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

159.73

Earnings Yield % (TTM)

-5.80%

Earnings Yield % (FWD)

-4.92%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.16

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$3.81M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$25.40

Close

$29.00

Volume / Avg.

302.89K / 516.92K

Day Range

$24.76 - $29.00

52 Wk Range

7.78 - 34.10

Market Cap

$375.52M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

24.22%

Days to Cover

3.41

About

Sector

Health Care

Industry

Biotechnology

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry